Form 4: Belite Bio CFO Sells Shares
Insider Transaction (Form 4)
Hao-Yuan Chuang, Chief Financial Officer and a Director of Belite Bio, Inc, sold 67,395 shares of common stock on September 4, 2026.
Summary
- Open-market sale: disposed of 1,633 American depositary share at $180.16 ($294,201) on September 4, 2026; holds 91,800 after (Direct).
- Open-market sale: disposed of 2,000 American depositary share at $181.05 ($362,107) on September 4, 2026; holds 89,800 after (Direct).
- Open-market sale: disposed of 2,000 American depositary share at $182.49 ($364,985) on September 4, 2026; holds 87,800 after (Direct).
- Open-market sale: disposed of 3,759 American depositary share at $183.27 ($688,899) on September 4, 2026; holds 84,041 after (Direct).
- Open-market sale: disposed of 3,569 American depositary share at $184.57 ($658,744) on September 4, 2026; holds 80,472 after (Direct).
- Open-market sale: disposed of 3,872 American depositary share at $185.28 ($717,408) on September 4, 2026; holds 76,600 after (Direct).
- Open-market sale: disposed of 4,600 American depositary share at $186.34 ($857,187) on September 4, 2026; holds 72,000 after (Direct).
- Open-market sale: disposed of 3,900 American depositary share at $187.16 ($729,942) on September 4, 2026; holds 68,100 after (Direct).
- Open-market sale: disposed of 1,900 American depositary share at $188.59 ($358,318) on September 4, 2026; holds 66,200 after (Direct).
- Open-market sale: disposed of 6,200 American depositary share at $189.22 ($1,173,191) on September 4, 2026; holds 60,000 after (Direct).
- Open-market sale: disposed of 1,800 American depositary share at $190.63 ($343,140) on September 4, 2026; holds 58,200 after (Direct).
- Open-market sale: disposed of 6,200 American depositary share at $191.09 ($1,184,754) on September 4, 2026; holds 52,000 after (Direct).
- Open-market sale: disposed of 3,398 American depositary share at $192.40 ($653,788) on September 4, 2026; holds 48,602 after (Direct).
- Open-market sale: disposed of 4,602 American depositary share at $193.12 ($888,727) on September 4, 2026; holds 44,000 after (Direct).
- Open-market sale: disposed of 2,200 American depositary share at $194.28 ($427,414) on September 8, 2026; holds 41,800 after (Direct).
- Open-market sale: disposed of 4,120 American depositary share at $195.60 ($805,889) on September 8, 2026; holds 37,680 after (Direct).
- Open-market sale: disposed of 4,475 American depositary share at $196.47 ($879,200) on September 8, 2026; holds 33,205 after (Direct).
- Open-market sale: disposed of 4,605 American depositary share at $197.23 ($908,244) on September 8, 2026; holds 28,600 after (Direct).
- Open-market sale: disposed of 2,562 American depositary share at $198.05 ($507,392) on September 8, 2026; holds 26,038 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $12,803,528 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Hao-Yuan Chuang — Director, Officer (Chief Financial Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-04 | Open-market sale | American depositary share | 1,633 | $180 | $294.2K | 91,800 |
| 2026-09-04 | Open-market sale | American depositary share | 2,000 | $181 | $362.1K | 89,800 |
| 2026-09-04 | Open-market sale | American depositary share | 2,000 | $182 | $365.0K | 87,800 |
| 2026-09-04 | Open-market sale | American depositary share | 3,759 | $183 | $688.9K | 84,041 |
| 2026-09-04 | Open-market sale | American depositary share | 3,569 | $185 | $658.7K | 80,472 |
| 2026-09-04 | Open-market sale | American depositary share | 3,872 | $185 | $717.4K | 76,600 |
| 2026-09-04 | Open-market sale | American depositary share | 4,600 | $186 | $857.2K | 72,000 |
| 2026-09-04 | Open-market sale | American depositary share | 3,900 | $187 | $729.9K | 68,100 |
| 2026-09-04 | Open-market sale | American depositary share | 1,900 | $189 | $358.3K | 66,200 |
| 2026-09-04 | Open-market sale | American depositary share | 6,200 | $189 | $1.2M | 60,000 |
| 2026-09-04 | Open-market sale | American depositary share | 1,800 | $191 | $343.1K | 58,200 |
| 2026-09-04 | Open-market sale | American depositary share | 6,200 | $191 | $1.2M | 52,000 |
| 2026-09-04 | Open-market sale | American depositary share | 3,398 | $192 | $653.8K | 48,602 |
| 2026-09-04 | Open-market sale | American depositary share | 4,602 | $193 | $888.7K | 44,000 |
| 2026-09-08 | Open-market sale | American depositary share | 2,200 | $194 | $427.4K | 41,800 |
| 2026-09-08 | Open-market sale | American depositary share | 4,120 | $196 | $805.9K | 37,680 |
| 2026-09-08 | Open-market sale | American depositary share | 4,475 | $196 | $879.2K | 33,205 |
| 2026-09-08 | Open-market sale | American depositary share | 4,605 | $197 | $908.2K | 28,600 |
| 2026-09-08 | Open-market sale | American depositary share | 2,562 | $198 | $507.4K | 26,038 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-04 | Open-market sale (1,633 shares) |
| 2026-09-04 | Open-market sale (2,000 shares) |
| 2026-09-04 | Open-market sale (2,000 shares) |
| 2026-09-04 | Open-market sale (3,759 shares) |
| 2026-09-04 | Open-market sale (3,569 shares) |
| 2026-09-04 | Open-market sale (3,872 shares) |
| 2026-09-04 | Open-market sale (4,600 shares) |
| 2026-09-04 | Open-market sale (3,900 shares) |
| 2026-09-04 | Open-market sale (1,900 shares) |
| 2026-09-04 | Open-market sale (6,200 shares) |
| 2026-09-04 | Open-market sale (1,800 shares) |
| 2026-09-04 | Open-market sale (6,200 shares) |
| 2026-09-04 | Open-market sale (3,398 shares) |
| 2026-09-04 | Open-market sale (4,602 shares) |
| 2026-09-08 | Open-market sale (2,200 shares) |
| 2026-09-08 | Open-market sale (4,120 shares) |
| 2026-09-08 | Open-market sale (4,475 shares) |
| 2026-09-08 | Open-market sale (4,605 shares) |
| 2026-09-08 | Open-market sale (2,562 shares) |
Keywords
insider transaction, Form 4, BLTE, BELITE BIO, INC, bearish, Hao-Yuan Chuang
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.